Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort.
EAMES, KT D; Brooks-Pollock, E; Paolotti, D; Perosa, M; Gioannini, C; EDMUNDS, WJ;
2011
Epidemiology and infection, (2011).140 7 10.1017/S0950268811001804.
Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea.
Lee, H; Cho, SN; Kim, HJ; Anh, YM; Choi, JE; Kim, CH; Ock, PJ; Oh, SH; Kim, DR; FLOYD, S; DOCKRELL, HM;
2011
Vaccine, (2011).29 38 10.1016/j.vaccine.2011.07.003.
Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.
Easton, A; Haque, A; Chu, K; Patel, N; Lukaszewski, RA; Krieg, AM; Titball, RW; BANCROFT, GJ;
2011
The Journal of infectious diseases, (2011).204 4 10.1093/infdis/jir301.
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
Wu, X; Zhou, T; Zhu, J; Zhang, B; Georgiev, I; Wang, C; Chen, X; Longo, NS; Louder, M; McKee, K; O'Dell, S; Perfetto, S; Schmidt, SD; Shi, W; Wu, L; Yang, Y; Yang, Z-Y; Yang, Z; Zhang, Z; Bonsignori, M; Crump, JA; KAPIGA, SH; Sam, NE; Haynes, BF; Simek, M; ... Mascola, JR.
2011
Science (New York, N.Y.), (2011).333 6049 10.1126/science.1207532.
Addressing the vaccine confidence gap.
LARSON, HJ; Cooper, LZ; Eskola, J; Katz, SL; Ratzan, S;
2011
Lancet, (2011).378 9790 10.1016/S0140-6736(11)60678-8.
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.
Vekemans, J; Marsh, K; GREENWOOD, B; Leach, A; Kabore, W; Soulanoudjingar, S; ASANTE, KP; Ansong, D; Evans, J; Sacarlal, J; Bejon, P; Kamthunzi, P; Salim, N; Njuguna, P; Hamel, MJ; Otieno, W; Gesase, S; SCHELLENBERG, D; Clinical Trials Partnership Committee,;
2011
Malaria journal, (2011).10 1 10.1186/1475-2875-10-221.
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine.
Swysen, C; Vekemans, J; Bruls, M; Oyakhirome, S; DRAKELEY, C; Kremsner, P; GREENWOOD, B; Ofori-Anyinam, O; Okech, B; Villafana, T; Carter, T; Savarese, B; Duse, A; Reijman, A; Ingram, C; Frean, J; Ogutu, B; Clinical Trials Partnership Committee,;
2011
Malaria journal, (2011).10 1 10.1186/1475-2875-10-223.
Post Marketing Vaccine Safety Monitoring in Low and Lower-Middle-Income Countries (LIC/LMIC).
Li, Y; Weibel, D; Eskola, J; LARSON, H; Zuber, P; Bonhoeffer, J;
2011
Pharmacoepidemiology and drug safety, (2011).20,
A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children.
Bélard, S; Issifou, S; Hounkpatin, AB; Schaumburg, F; Ngoa, UA; Esen, M; Fendel, R; De Salazar, PM; Mürbeth, RE; MILLIGAN, P; Imbault, N; Imoukhuede, EB; Theisen, M; Jepsen, S; Noor, RA; Okech, B; Kremsner, PG; Mordmüller, B;
2011
PloS one, (2011).6 7 10.1371/journal.pone.0022525.
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors.
Bonsignori, M; Hwang, K-K; Chen, X; Tsao, C-Y; Morris, L; Gray, E; Marshall, DJ; Crump, JA; KAPIGA, SH; Sam, NE; Sinangil, F; Pancera, M; Yongping, Y; Zhang, B; Zhu, J; Kwong, PD; O'Dell, S; Mascola, JR; Wu, L; Nabel, GJ; Phogat, S; Seaman, MS; Whitesides, JF; Moody, MA; Kelsoe, G; ... Haynes, BF.
2011
Journal of virology, (2011).85 19 10.1128/JVI.05045-11.